Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours

被引:35
作者
Kirk, SM
Schell, RF
Moore, AV
Callister, SM
Mazurek, GH
机构
[1] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA
[4] Gundersen Lutheran Med Ctr, Dept Infect Dis, La Crosse, WI 54601 USA
[5] Gundersen Lutheran Med Ctr, Microbiol Res Lab, La Crosse, WI 54601 USA
[6] Biorad Labs, Hercules, CA 94547 USA
[7] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
D O I
10.1128/JCM.36.6.1568-1573.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Susceptibility testing of Mycobacterium tuberculosis is seriously limited by the time required to obtain results. We show that susceptibility testing of clinical isolates of M. tuberculosis can be accomplished rapidly with acceptable accuracy by using flow cytometry, The susceptibilities of 35 clinical isolates of M. tuberculosis to various concentrations of isoniazid, rifampin, and ethambutol were tested by the agar proportion method and by flow cytometry, Agreement between the results from the two methods was 95, 92, and 83% for isoniazid, ethambutol, and rifampin, respectively. Only 11 discrepancies were detected among 155 total tests. The results of bow cytometric susceptibility tests were available within 24 h of inoculation of drug-containing medium, while the proportion method required 3 weeks to complete. The flow cytometric method is also simple to perform.
引用
收藏
页码:1568 / 1573
页数:6
相关论文
共 36 条
[1]  
[Anonymous], FLOW CYTOMETRY SORTI
[2]   Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery [J].
Arain, TM ;
Resconi, AE ;
Hickey, MJ ;
Stover, CK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1536-1541
[3]   Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins [J].
Bardou, F ;
Quemard, A ;
Dupont, MA ;
Horn, C ;
Marchal, G ;
Daffe, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2459-2467
[4]   NATIONWIDE SURVEY OF DRUG-RESISTANT TUBERCULOSIS IN THE UNITED-STATES [J].
BLOCH, AB ;
CAUTHEN, GM ;
ONORATO, IM ;
DANSBURY, KG ;
KELLY, GD ;
DRIVER, CR ;
SNIDER, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :665-671
[5]   Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry [J].
Bownds, S ;
Kurzynski, TA ;
Norden, MA ;
Dufek, JL ;
Schell, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1386-1390
[6]  
CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565
[7]  
Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V45, P365
[8]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[9]   Estimation of the annual risk of tuberculous infection for white men in the United States [J].
Daniel, TM ;
Debanne, SM .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1535-1537
[10]   Flow cytometry and cell sorting of heterogeneous microbial populations: The importance of single-cell analyses [J].
Davey, HM ;
Kell, DB .
MICROBIOLOGICAL REVIEWS, 1996, 60 (04) :641-+